Limbix

Amitriptyline USP & Chlordiazepoxide USP

CNS » ANXIOLYTIC, » ANTI-DEPRESSANT

INDICATION

LIMBIX is indicated for the treatment of patients with moderate to severe depression associated with moderate to severe anxiety. Symptoms likely to respond in the first week of treatment include: insomnia, feelings of guilt or worthlessness, agitation, psychic and somatic anxiety, suicidal ideation and anorexia.

DOSAGE AND ADMINISTRATION

Optimum dosage varies with the severity of the symptoms and the response of the individual patient. When a satisfactory response is obtained, dosage should be reduced to the smallest amount needed to maintain the remission. The larger portion of the total daily dose may be taken at bedtime. In some patients, a single dose at bedtime may be sufficient.

LIMBIX Tablets in an initial dosage of 3 or 4 tablets daily in divided doses is satisfactory.

OR AS DIRECTED BY THE PHYSICIAN.

COMPOSITION

Each tablet contains Amitriptyline Hydrochloride USP 14.15 mg (equivalent to 12.5 mg Amitriptyline) + Chlordiazepoxide USP 5 mg.